These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 4388423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of immune and natural specific antibodies in immunologic paralysis and immunity of mice to pneumococcal polysaccharide type 3.
    Kerman R, Segre D, Myers WL.
    J Immunol; 1970 Mar; 104(3):656-64. PubMed ID: 4190969
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    Baker PJ, Stashak PW, Amsbaugh DF, Prescott B.
    J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of the antibody response to type III pneumococcal polysaccharide with antigen coupled to syngeneic lymphoid cells.
    Braley-Mullen H.
    Cell Immunol; 1980 Jun; 52(1):132-9. PubMed ID: 6156010
    [No Abstract] [Full Text] [Related]

  • 9. Immunological paralysis of mice with pneumococcal polysaccharide antigens.
    Halliday WJ.
    Bacteriol Rev; 1971 Sep; 35(3):267-89. PubMed ID: 4398890
    [No Abstract] [Full Text] [Related]

  • 10. Maternal immunization and the immune response of neonates to pneumococcal polysaccharides.
    Lee CJ, Takaoka Y, Saito T.
    Rev Infect Dis; 1987 Sep; 9(3):494-510. PubMed ID: 2955505
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The induction of immunologic tolerance with type III pneumococcal polysaccharide cross-linked or coupled to protein.
    McMaster PR, Owens JD, Prescott B, Finerty J, Weichbrod R.
    Ann Immunol (Paris); 1978 Sep; 129(2-3):337-45. PubMed ID: 79330
    [Abstract] [Full Text] [Related]

  • 17. Anti-pneumococcal polysaccharide type 3 hemolytic plaques in mice: cellular response in immunity and immunologic paralysis.
    Kerman R, Segre D.
    J Immunol; 1970 May; 104(5):1262-6. PubMed ID: 4392712
    [No Abstract] [Full Text] [Related]

  • 18. Specific suppression of the antibody response in vitro by serum from paralyzed mice.
    Brown PB, Köhler H, Rowley DA.
    J Immunol; 1975 Aug; 115(2):419-24. PubMed ID: 239061
    [Abstract] [Full Text] [Related]

  • 19. Studies on immunological paralysis. II. The detection and significance of antibod-forming cells in the spleen during immunological paralysis with type 3 pneumococcal polysaccharide.
    Howard JG, Elson J, Christie GH, Kinsky RG.
    Clin Exp Immunol; 1969 Jan; 4(1):41-53. PubMed ID: 4389161
    [Abstract] [Full Text] [Related]

  • 20. Treadmill neutralization of antibody and central inhibition. Separate components of pneumococcal polysaccharide paralysis.
    Howard JG, Christie GH, Courtenay BM.
    Transplantation; 1970 Oct; 10(4):251-3. PubMed ID: 4396243
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.